WuXi Clinical, a wholly owned subsidiary of WuXi AppTec, is a global CRO providing a comprehensive range of services in clinical development. We provide Phase I to Phase IV research for pharmaceuticals, biologics, and medical devices. With expertise spanning across all major therapeutic areas including oncology, we deliver the unique blend of an experienced team combined with data-driven insights and responsiveness for better outcomes. Our forward-thinking approach has allowed us to accelerate a variety of clinical projects ranging from first-in-human products to marketed drugs and devices.